{"id":"jincaopian-tablets","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL942","moleculeType":"Small molecule","molecularWeight":"361.40"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The tablet formulation combines herbal components traditionally used in Chinese medicine to support respiratory health and immune function. While the exact molecular targets are not well-characterized in Western pharmacological literature, the preparation is believed to work through multiple pathways including anti-inflammatory and immunomodulatory effects. The specific active constituents and their mechanisms require further clinical characterization.","oneSentence":"Jincaopian Tablets is a traditional Chinese medicine formulation that modulates immune function and inflammatory pathways to treat respiratory and immune-related conditions.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:17:36.019Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Respiratory conditions and immune support (specific indication under Phase 3 evaluation)"}]},"trialDetails":[{"nctId":"NCT05970783","phase":"PHASE3","title":"A Study of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease","status":"RECRUITING","sponsor":"Beijing Konruns Pharmaceutical Co., Ltd.","startDate":"2022-11-08","conditions":"Chronic Pelvic Pain","enrollment":414},{"nctId":"NCT05460546","phase":"PHASE2","title":"The Effect of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease","status":"COMPLETED","sponsor":"Beijing Konruns Pharmaceutical Co., Ltd.","startDate":"2021-01-19","conditions":"Chronic Pelvic Pain","enrollment":180}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["ZY5301"],"phase":"phase_3","status":"active","brandName":"Jincaopian Tablets","genericName":"Jincaopian Tablets","companyName":"Beijing Konruns Pharmaceutical Co., Ltd.","companyId":"beijing-konruns-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Jincaopian Tablets is a traditional Chinese medicine formulation that modulates immune function and inflammatory pathways to treat respiratory and immune-related conditions. Used for Respiratory conditions and immune support (specific indication under Phase 3 evaluation).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}